CEP-8983

Modify Date: 2024-01-23 18:47:01

CEP-8983 Structure
CEP-8983 structure
Common Name CEP-8983
CAS Number 374071-46-2 Molecular Weight 306.31500
Density N/A Boiling Point N/A
Molecular Formula C18H14N2O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CEP-8983


CEP-8983 is a PARP-1 and PARP-2 inhibitor (IC50: 20 and 6 nM). CEP-8983 is an effective chemosensitizing agent, and can sensitize chemotherapy-resistant cell lines and subcutaneous xenografts to Temozolomide (HY-17364) and Camptothecin (HY-16560)[1].

 Names

Name 4,5,6,7-tetrahydro-11-methoxy-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)dione
Synonym More Synonyms

 CEP-8983 Biological Activity

Description CEP-8983 is a PARP-1 and PARP-2 inhibitor (IC50: 20 and 6 nM). CEP-8983 is an effective chemosensitizing agent, and can sensitize chemotherapy-resistant cell lines and subcutaneous xenografts to Temozolomide (HY-17364) and Camptothecin (HY-16560)[1].
Related Catalog
Target

20 and 6 nM (PARP-1/2)[1].

References

[1]. Miknyoczki S, et al. The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity. Mol Cancer Ther. 2007 Aug;6(8):2290-302.  

 Chemical & Physical Properties

Molecular Formula C18H14N2O3
Molecular Weight 306.31500
Exact Mass 306.10000
PSA 74.68000
LogP 2.71240

 Synthetic Route

~%

CEP-8983 Structure

CEP-8983

CAS#:374071-46-2

Literature: CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

CEP-8983 Structure

CEP-8983

CAS#:374071-46-2

Literature: CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

CEP-8983 Structure

CEP-8983

CAS#:374071-46-2

Literature: CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ; Location in patent: Page/Page column 19; 24 ;

~%

CEP-8983 Structure

CEP-8983

CAS#:374071-46-2

Literature: CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

CEP-8983 Structure

CEP-8983

CAS#:374071-46-2

Literature: CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

~%

CEP-8983 Structure

CEP-8983

CAS#:374071-46-2

Literature: CEPHALON, INC.; BIERLMAIER, Stephen; CHRISTIE, Michael; COURVOISIER, Laurent; FIELD, R. Scott; HALTIWANGER, R. Curtis; HE, Linli; JACOBS, Martin J.; KRESS, Michael; MCKEAN, Robert E.; MOWREY, Dale R.; PETRAITIS, Joseph; YAZDANIAN, Mehran Patent: WO2011/28580 A1, 2011 ;

 Synonyms

7-methoxy-1,2,3,11-tetrahydro-5,11-diaza-benzo[a]trindene-4,6-dione
1H-Cyclopenta(a)pyrrolo(3,4-c)carbazole-1,3(2H)-dione,4,5,6,7-tetrahydro-11-methoxy